Signaling pathways
-
BA7720 FT113Summary: FT113 is a potent, orally available fatty acid synthase inhibitor. - BA7721 FGH10019Summary: FGH10019 is a sterol regulatory element binding protein inhibitor.
- BA7722 FASN-IN-1Summary: A fatty acid synthase inhibitor.
- BA7723 FASN-IN-5Summary: FASN-IN-5 is an inhibitor.
- BA7724 FBPase-IN-1Summary: FBPase-IN-1 is a potent (Fructose-1,6-bisphosphatase) inhibitor.
- BA7728 BOS-318Summary: BOS-318 is a potent, slowly dissociating, highly selective, inhibitor of cell permeability.
- BA7729 DY268Summary: DY268 is an antagonist of the farnesoid X receptor (=7.5 nM).
- BA7730 OmesdafexorSummary: Omesdafexor is an agonist.
- BA7731 NDBSummary: NDB is a selective human antagonist that efficiently regulates the transcription of genes downstream of FXRα.
- BA7732 HEC96719Summary: HEC96719 is a selective as well as orally active tricyclic farnesoid X receptor agonist with values of 1.37 and 1.55 nM by time-resolved fluorescence energy transfer (TR-FRET) and luciferase reporter assays, respectively.